Brokerages Set IQVIA Holdings Inc. (NYSE:IQV) Price Target at $257.57

IQVIA Holdings Inc. (NYSE:IQVGet Rating) has received an average recommendation of “Moderate Buy” from the sixteen analysts that are presently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $257.57.

IQV has been the topic of several research reports. Guggenheim increased their price target on shares of IQVIA to $249.00 in a report on Thursday, October 27th. Morgan Stanley cut their price target on shares of IQVIA from $260.00 to $240.00 and set an “overweight” rating on the stock in a report on Thursday, October 27th. Argus increased their price target on shares of IQVIA from $260.00 to $275.00 in a report on Thursday, August 18th. Mizuho cut their price target on shares of IQVIA from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Thursday, November 10th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of IQVIA from $290.00 to $270.00 in a research note on Tuesday, October 18th.

IQVIA Stock Performance

Shares of IQVIA stock opened at $217.72 on Friday. IQVIA has a 52 week low of $165.75 and a 52 week high of $285.61. The company has a 50 day moving average price of $197.16 and a 200 day moving average price of $210.60. The company has a quick ratio of 0.90, a current ratio of 0.90 and a debt-to-equity ratio of 2.29. The firm has a market capitalization of $40.44 billion, a P/E ratio of 35.46, a PEG ratio of 2.07 and a beta of 1.37.

Institutional Investors Weigh In On IQVIA

A number of institutional investors have recently added to or reduced their stakes in IQV. Knott David M Jr acquired a new stake in IQVIA in the 2nd quarter valued at $26,000. Clear Investment Research LLC acquired a new stake in IQVIA in the 3rd quarter valued at $27,000. Quent Capital LLC grew its stake in IQVIA by 271.8% in the 1st quarter. Quent Capital LLC now owns 145 shares of the medical research company’s stock valued at $34,000 after acquiring an additional 106 shares during the period. EverSource Wealth Advisors LLC grew its stake in IQVIA by 243.2% in the 1st quarter. EverSource Wealth Advisors LLC now owns 151 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 107 shares during the period. Finally, Total Clarity Wealth Management Inc. purchased a new position in IQVIA in the 2nd quarter valued at $41,000. Institutional investors and hedge funds own 86.77% of the company’s stock.

About IQVIA

(Get Rating)

IQVIA Holdings, Inc engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions and real-world solutions and services to the firm’s life science clients.

Read More

Analyst Recommendations for IQVIA (NYSE:IQV)

Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.